The U.S. Food and Drug Administration has approved Menactra for children as young as 9 months for the prevention of meningococcal disease. Read more at http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm252392.htm.
© 2021 HealthCom Media All rights reserved. No part of this website or publication may be reproduced, stored, or transmitted in any form or by any means, electronic or mechanical, including photocopy, recording, or any information storage and retrieval system, without permission in writing from the copyright holder.